+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Trends in incidence of breast cancer among women under 40 in seven European countries: a GRELL cooperative study



Trends in incidence of breast cancer among women under 40 in seven European countries: a GRELL cooperative study



Cancer Epidemiology 37(5): 544-549



Young women are not usually screened for breast cancer (BC). The trends in incidence in this population may better reflect changes in risk factors. However, studies on this subject are scarce and heterogeneous. The aim of this study was to describe the trends in incidence of BC in women under 40 from 1990 to 2008, using pooled European data. Thirty-seven European population-based cancer registries from Belgium, Bulgaria, France, Italy, Portugal, Spain and Switzerland participated in this study. World age-standardized incidence rates were first analyzed graphically and then using a Poisson regression model, in order to estimate average annual percent changes (AAPCs). The overall incidence rate of BC in the area covered increased linearly during the study period by 1.19% (0.93; 1.46) on average per year. This increase varied between countries from 0.20% (-0.53; 0.64) in Bulgaria to 2.68% (1.97; 3.40) in Portugal. In Italy, after a significant rise of 2.33% (1.14; 3.54) per year, BC incidence began decreasing in 2002 by -2.30% (-4.07; -0.50) yearly. The rise in incidence was greater for women under 35 and for ductal carcinomas. This increase can be due to a rise in risk factors and/or changes in diagnosis and surveillance practices, but we could not clearly distinguish between these two non-exclusive explanations.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056686386

Download citation: RISBibTeXText

PMID: 23768969

DOI: 10.1016/j.canep.2013.05.001


Related references

Breast cancer incidence and mortality trends in 16 European countries. European Journal of Cancer 39(12): 1718-1729, August, 2003

Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study. Journal of Clinical Oncology 12(6): 1266-1271, 1994

Breast cancer incidence trends in European women aged 20-39 years at diagnosis. Breast Cancer Research and Treatment 134(1): 363-370, 2012

Consistency and inconsistency in testing biomarkers in breast cancer. A GRELL study in cut-off variability in the Romance language countries. Breast 22(4): 476-481, 2014

Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group. Journal of Clinical Oncology 26(30): 4883-4890, 2008

Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory. European Journal of Cancer 51(9): 1164-1187, 2015

Prostate cancer incidence and mortality trends in 37 European countries: an overview. European Journal of Cancer 46(17): 3040-3052, 2011

Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiology, Biomarkers & Prevention 13(12): 2157-2166, 2004

Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. International Journal of Cancer 118(12): 3099-3111, 2006

Trends in incidence of female breast cancer in the nordic countries. Magnus, K (Ed ) Trends in Cancer Incidence: Causes And Practical Implications; Symposium, Oslo, Norway, Aug 6-7, 1980 Xvii+446p Hemisphere Publishing Corporation: Washington, D C , Usa; London, England Illus P235-248, 1982

High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. Journal of Clinical Oncology 18(5): 1075-1083, 2000

Carminomycin vs. doxorubicin in advanced breast cancer a randomized phase ii study of the european organization for research on treatment of cancer breast cancer cooperative group. European Journal of Cancer and Clinical Oncology 22(5): 601-606, 1986

Temporal trends in age-specific incidence and mortality of breast cancer in 38 countries. 2007

Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: a double-blind randomized study. European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group. Journal of Clinical Oncology 11(9): 1723-1728, 1993